What Is Sperm Count Decline 2026?
Sperm count decline refers to the documented drop in sperm concentration and total sperm count in men’s semen samples measured across decades of research. Scientists track this through two main figures: sperm concentration, the number of sperm per milliliter of semen, and total sperm count, which multiplies that concentration by the full volume of an ejaculate. Since the early 1990s, researchers have periodically pooled hundreds of individual studies from around the world to see whether these numbers are moving, and for years the answer from the largest global analyses has been a clear yes, prompting real concern among reproductive health researchers about long-term male fertility trends.
In the United States in 2026, the picture is more complicated and more interesting than most headlines suggest. The most-cited global research still points to a real, decades-long decline concentrated in Western countries. But a major new US-specific study published in a leading fertility journal in January 2025 challenges that narrative directly for the American male population specifically, finding no clinically significant drop in sperm concentration among confirmed fertile US men. This guide lays out both sides of that debate using the actual published data, along with the broader statistics on male infertility, testosterone trends, environmental risk factors, and fertility treatment that round out the current state of male reproductive health in the US.
Interesting Facts About Sperm Count Decline in the US 2026
Sperm Count Research: The Two Competing Pictures
Global decline, Western countries, 1973-2011 |████████████████████████████ 52.4%
Global decline, worldwide, 1973-2018 |████████████████████████████ 51.6%
US-specific study: total sperm count change |█ +2.9M/year (increase)
Men ages 15-49 with some infertility, US |███████ 11.4%
| Interesting Fact | Figure |
|---|---|
| Global decline in sperm concentration, Western countries, 1973-2011 | 52.4% |
| Global decline in sperm concentration, worldwide, 1973-2018 | 51.6% |
| US-specific study (2025): change in mean total sperm count, 1970-2018 | +2.9 million per year (increase) |
| Post-2000 rate of global decline vs. post-1973 rate | More than doubled |
| Men ages 15-49 in the US with some form of infertility | 11.4% |
| Male factor’s contribution to overall couple infertility | About one-third |
| Decline in average testosterone, young US men, 1999-2000 to 2015-2016 | ~25% |
| US branded semen-quality studies included in the 2025 US-specific analysis | 75 study populations, 11,787 men |
Source: Human Reproduction Update, 2017 and 2022; Fertility and Sterility, January 2025; NHANES-based testosterone research.
The two headline numbers above sound like they can’t both be true, and that tension is exactly what makes this such an active area of research right now. The widely cited global meta-analyses, led by researcher Hagai Levine and colleagues, found sperm concentration fell 52.4% in Western countries between 1973 and 2011, and when the analysis was expanded worldwide through 2018, the 51.6% decline held up and the rate of decline had more than doubled since 2000. Those figures have shaped nearly every news story on this topic for almost a decade. But a 2025 US-specific study published in Fertility and Sterility, drawing on 75 study populations covering 11,787 American men, found no such pattern domestically, and even found total sperm count had modestly increased over the same general period.
Away from that specific debate, the broader male fertility picture in the US is well documented. 11.4% of men ages 15 to 49 report some form of infertility, and male factors contribute to roughly one-third of all couple infertility cases nationally. Average testosterone levels in young American men fell by roughly 25% between 1999 and 2016 according to national health survey data, a separate but related trend that researchers are still working to fully explain. The sections below walk through each of these threads individually, including the actual study designs behind the competing sperm count claims, so the numbers can be read in proper context rather than as a single simple headline.
Global Sperm Count Decline Statistics in the US 2026
Levine et al. 2017 Meta-Analysis, Western Countries
Sperm concentration decline, 1973-2011 |████████████████████ 52.4%
Total sperm count decline, 1973-2011 |████████████████████████ 59.3%
Studies included | 185 studies, ~43,000 men
| Metric (Levine et al., 2017) | Figure |
|---|---|
| Decline in sperm concentration, Western countries, 1973-2011 | 52.4% |
| Decline in total sperm count, Western countries, 1973-2011 | 59.3% |
| Studies analyzed | 185 studies |
| Total men included | Nearly 43,000 |
| Regions covered | North America, Europe, Australia, New Zealand |
Source: Human Reproduction Update, 2017 (Levine, Swan, et al.).
The study that put sperm count decline on the public radar was a 2017 meta-analysis led by epidemiologist Hagai Levine of Hebrew University and reproductive health researcher Shanna Swan at the Icahn School of Medicine, published in the journal Human Reproduction Update. Drawing on 185 studies covering nearly 43,000 men, the researchers found sperm concentration fell 52.4% and total sperm count fell 59.3% between 1973 and 2011 across Western countries, a group that includes North America, Europe, Australia, and New Zealand. The finding drew wide media coverage at the time, with Dr. Swan telling reporters the trend appeared not to be leveling off and calling the pattern “extremely worrisome.”
Critics of this and earlier similar studies have raised methodological concerns worth noting for balance. A commentary in the British Columbia Medical Journal pointed out that much of the earliest data used to establish a declining baseline came disproportionately from a small number of clinics, notably New York, before 1970, and that removing that specific data reversed the trend in at least one earlier foundational analysis. Sperm count researchers generally acknowledge that pooling decades of studies that used different lab methods, different populations, and different definitions of “fertile” versus “unselected” men introduces real heterogeneity, which is exactly the kind of complexity that later, more tightly controlled research has tried to address.
Accelerating Sperm Decline Trends Statistics in the US 2026
Levine et al. 2022 Update, Global Scope
Sperm concentration decline, worldwide, 1973-2018 |███████████████████████ 51.6%
Total sperm count decline, worldwide, 1973-2018 |█████████████████████████████ 62.3%
Decline rate, pre-2000 |█ 1.16% per year
Decline rate, post-2000 |██ 2.64% per year
| Metric (Levine et al., 2022 update) | Figure |
|---|---|
| Sperm concentration decline, worldwide, 1973-2018 | 51.6% |
| Total sperm count decline, worldwide, 1973-2018 | 62.3% |
| Annual decline rate, post-1973 | 1.16% per year |
| Annual decline rate, post-2000 | 2.64% per year |
| Geographic expansion vs. 2017 study | Added Asia, Africa, Central and South America |
Source: Human Reproduction Update, November 2022 (Levine et al. meta-regression update).
A 2022 update to the original analysis, again led by Levine’s team and published in the same journal, extended the geographic scope beyond Western countries for the first time, adding data from Asia, Africa, and Central and South America. The updated model found sperm concentration among unselected men worldwide declined 51.6% between 1973 and 2018, with total sperm count falling 62.3% over the same window, confirming that the pattern the researchers had identified in 2017 was not simply a Western phenomenon. The most striking finding in the update was the pace of change: the rate of decline more than doubled after the year 2000, climbing from 1.16% per year in the earlier decades to 2.64% per year in the 21st century portion of the dataset.
That acceleration finding is what turned this from a historical curiosity into an active policy concern for researchers, since a steady, gradual decline reads very differently than one that appears to be speeding up. The 2022 update also found statistically significant declines specifically among unselected men in Northeast Asia and fertile men in Northeast Asia, regions that had limited representation in the original 2017 analysis, strengthening the case that this pattern extends well beyond the wealthy, industrialized nations first studied. It’s this global trajectory, rather than any single country’s numbers, that has driven most of the public concern and funding attention toward sperm count research over the past several years.
US-Specific Sperm Concentration Statistics in the US 2026
2025 US-Specific Study, Fertility and Sterility
Unadjusted change in sperm concentration, 1970-2018 |0.14 million/mL per year (no significant change)
Adjusted for region + fertility status |-0.35 million/mL per year (modest decline)
Total sperm count change, 1970-2018 |+2.9 million per year (increase)
Study populations included |75 populations, 11,787 US men
| Metric (Fertility and Sterility, January 2025) | Figure |
|---|---|
| Unadjusted change in sperm concentration, US, 1970-2018 | +0.14 million/mL per year (no significant change) |
| Change when adjusted for region only | No statistically significant decline |
| Change when adjusted for region and fertility status | -0.35 million/mL per year (modest, statistically significant) |
| Change in total sperm count, 1970-2018 | +2.9 million per year (significant increase) |
| Studies screened / included | 874 screened, 58 met inclusion criteria |
Source: Fertility and Sterility, January 2025 (systematic review and meta-analysis).
The most direct challenge to the global decline narrative, at least as it applies specifically to the United States, came from a systematic review and meta-analysis published in Fertility and Sterility in January 2025. Researchers screened 874 articles and included 58 that met their criteria, representing 75 unique study populations and 11,787 American men studied between 1970 and 2023. In their primary, unadjusted model, they found essentially no change in sperm concentration between 1970 and 2018, and when they adjusted for US region alone, still found no statistically significant decline. Only when the model adjusted for both region and fertility status together did a decline emerge, and even then it was modest, at -0.35 million/mL per year, a fraction of the pace implied by the global figures.
Perhaps the most surprising finding came from total sperm count, the metric that combines concentration with ejaculate volume. Among the 49 study populations with adequate data to calculate it, the researchers found a statistically significant increase of 2.9 million sperm per year between 1970 and 2018, the opposite direction from what the global meta-analyses would predict. The study’s authors concluded plainly that their analysis suggests “no clinically significant decline in sperm concentration among confirmed fertile men and the general male US population without known infertility,” a direct contrast to the global studies. Both sets of findings are published in credible, peer-reviewed venues, and reconciling them will likely require future research that more tightly controls for laboratory methodology and population selection across countries, something both research teams have acknowledged is a genuine limitation of pooling decades of heterogeneous historical data.
Male Infertility Prevalence Statistics in the US 2026
Male Infertility Prevalence, US
Men ages 15-49 with some infertility |█████ 11.4%
Men ages 25-49 (prime years) |██████ 12.8%
Male factor, contribution to couple infertility |████████████ ~33%
Male factor, sole identifiable cause |███ 8%
| Male Infertility Metric | Figure |
|---|---|
| Men ages 15-49 with some form of infertility | 11.4% |
| Men ages 25-49 (prime reproductive years) | 12.8% |
| Male factor’s contribution to overall couple infertility | About 33% |
| Cases where male factor is the sole identifiable cause | About 8% |
| Male infertility cases with no identifiable cause (idiopathic) | About 75% |
Source: CDC-derived US infertility survey data; UNSW research compilation, 2022.
Male infertility affects a meaningful share of American men even setting aside the sperm-count debate entirely. 11.4% of men ages 15 to 49 report experiencing some form of infertility, whether subfertility or complete sterility, and that figure climbs slightly to 12.8% among men in their prime reproductive years of 25 to 49. Looking at the couple level rather than individual men, male factors contribute to roughly one-third of all infertility cases where a couple is struggling to conceive, and in about 8% of cases, a male factor is identified as the sole cause with no contributing female factor found. These numbers place male infertility on comparable footing with female infertility as a driver of the roughly one-in-six couples worldwide who experience difficulty conceiving.
What complicates treatment and research alike is how often the underlying cause remains unclear. Roughly 75% of male infertility cases have no clearly identifiable cause even after a full clinical workup, according to research compiled by the University of New South Wales, a category doctors describe as idiopathic infertility. That high rate of unexplained cases is part of why environmental and lifestyle factors, discussed further down, get so much research attention: when a specific anatomical or genetic cause can’t be pinned down, researchers look toward broader population-level exposures that might explain trends across large groups of men rather than any single patient’s diagnosis.
Varicocele and Diagnosable Male Fertility Causes Statistics in the US 2026
Varicocele Prevalence by Infertility Status, US
General male population |█████████ 15%
Men with primary infertility |████████████ 25-35%
Men with secondary infertility |███████████████████ 50-80%
| Diagnosable Cause | Prevalence |
|---|---|
| Varicocele, general male population | 15% |
| Varicocele, men with primary infertility | 25% to 35% |
| Varicocele, men with secondary infertility | 50% to 80% |
| Azoospermia (complete absence of sperm), infertile men | 10% to 15% |
| Azoospermia, general male population | About 1% |
Source: US infertility statistics compilation, CDC-derived data, 2025.
Among the identifiable causes of male infertility, varicocele, an enlargement of the veins within the scrotum similar to varicose veins elsewhere in the body, stands out as the single most common diagnosis. It affects 15% of all men in the general population, a rate that climbs sharply to 25% to 35% among men experiencing primary infertility, meaning they have never fathered a pregnancy, and reaches as high as 50% to 80% among men with secondary infertility, meaning they previously fathered a pregnancy but now cannot. That dramatic jump across infertility categories is one of the clearer, most consistent patterns in male reproductive medicine, and it’s a large part of why a physical exam for varicocele is one of the first steps in a standard male fertility workup.
Azoospermia, the complete absence of sperm in the ejaculate, represents a smaller but more severe category. It affects only about 1% of men in the general population, but among men already diagnosed with infertility, that share rises to 10% to 15%, making it one of the more common findings once a couple has already sought fertility evaluation. Unlike varicocele, which is often surgically correctable, azoospermia’s causes range widely from blockages in the reproductive tract that can sometimes be bypassed surgically to complete testicular failure that may require donor sperm or other assisted reproduction approaches, which is part of why an accurate diagnosis matters so much for the treatment path a couple ultimately pursues.
Testosterone Decline Statistics in the US 2026
Average Total Testosterone, Young US Men (NHANES)
1999-2000 |████████████████████████████████████████ 605 ng/dL
2015-2016 |██████████████████████████████ 451 ng/dL
Decline ~25%| Testosterone Metric | Figure |
|---|---|
| Average total testosterone, young US men, 1999-2000 | 605 ng/dL |
| Average total testosterone, young US men, 2015-2016 | 451 ng/dL |
| Overall decline | About 25% |
| Decline among men with healthy body weight specifically | 665 → 529 ng/dL, about 20% |
| Typical age-related decline rate after age 30, for comparison | 1% to 2% per year |
Source: NHANES-derived testosterone trend data, cross-survey-cycle analysis.
Running parallel to the sperm count debate is a separate, somewhat better-documented trend in testosterone levels. Analysis of national health survey data found average total testosterone among young American men fell from 605 ng/dL in the 1999-2000 survey cycle to 451 ng/dL by 2015-2016, a drop of roughly 25% over that 16-year span. What makes this trend harder to dismiss as simply a byproduct of rising obesity rates is that the decline held up even when researchers isolated men with a healthy body weight specifically, whose average testosterone still fell from 665 ng/dL to 529 ng/dL, about a 20% drop, over the same period. For context, testosterone naturally declines with individual age at a rate of roughly 1% to 2% per year after age 30, so a 25% population-level shift in young men specifically points to something beyond ordinary aging.
Researchers studying this pattern describe it as a genuine, age-independent, generational shift rather than a measurement artifact, though the underlying causes remain an active area of investigation, with obesity, metabolic health changes, environmental exposures, and lifestyle factors all cited as likely contributors rather than any single confirmed cause. Testosterone and sperm production are regulated through related but distinct hormonal pathways, so a decline in one does not automatically mean an equivalent decline in the other, but researchers generally view the two trends as plausibly connected given that both point toward broader shifts in male reproductive and hormonal health across the same generational timeframe.
Environmental and Endocrine Disruptor Statistics in the US 2026
| Environmental Factor | Documented Finding |
|---|---|
| Microplastics detected in human testicular tissue and semen | Confirmed in multiple published studies |
| Phthalate exposure crossover study: decrease in LH (luteinizing hormone) | 13.9% |
| Animal (mouse) studies: testosterone reduction from BPA/phthalate exposure | Up to 40% |
| California State Legislature 2023 evidence review conclusion | Microplastics “suspected” to adversely impact sperm quality |
Source: Environmental toxicology research compilation, 2022-2026; California State Legislature evidence review, 2023.
A significant share of current research into male reproductive health is focused on endocrine-disrupting chemicals, compounds like BPA and phthalates found widely in plastics, food packaging, and personal care products, that can interfere with the hormonal signals driving sperm production. Multiple published studies have now confirmed the presence of microplastics directly in human testicular tissue and semen samples, moving the concern from a theoretical exposure pathway to a documented physical finding. Mechanistically, researchers point to how BPA can reduce the pituitary gland’s secretion of luteinizing hormone, which in turn lowers the stimulation Leydig cells need to produce testosterone locally within the testes, while phthalates separately inhibit the enzymes that drive steroid hormone synthesis. A human crossover study specifically measuring phthalate exposure found a 13.9% decrease in LH levels among newly exposed men.
It’s important to be precise about what level of evidence supports each specific claim in this area. The 40% reduction in testosterone figure comes from controlled animal studies, primarily in mice, rather than from human population data, and researchers are careful to note that animal findings don’t automatically translate one-to-one to human biology. A 2023 evidence review conducted for the California State Legislature summarized the state of the science more cautiously, concluding that microplastics are “suspected” to adversely affect sperm quality and testicular health in humans based on the mechanistic and animal evidence available, language that reflects a real and active research question rather than a settled scientific fact. What researchers generally agree on is timing: the documented decline in sperm counts over the past 50 to 60 years has roughly coincided with the global explosion in plastic production and use, a pattern epidemiologist Shanna Swan has pointed to directly, though correlation of that kind is not the same as proven causation, and untangling it from the many other changes in modern life that occurred over the same decades remains an open scientific challenge. For broader context on how these exposures fit into general male health patterns, the Men’s Health Statistics in the U.S report covers the wider landscape of conditions and risk factors affecting American men.
Lifestyle Risk Factor Statistics in the US 2026
Established Lifestyle Risk Factors for Male Fertility
Obesity Well-documented risk factor
Smoking / tobacco use Well-documented risk factor
Heavy alcohol use Well-documented risk factor
Scrotal heat exposure Well-documented risk factor
Chronic psychological stress Well-documented risk factor
| Lifestyle Risk Factor | Documented Association |
|---|---|
| Obesity / excess body weight | Associated with reduced semen quality and hormonal disruption |
| Tobacco and cigarette use | Associated with lower sperm count and motility |
| Heavy or frequent alcohol use | Associated with reduced testosterone and semen quality |
| Prolonged scrotal heat exposure (hot tubs, laptops, tight clothing) | Associated with temporary reductions in sperm production |
| Chronic psychological stress and insufficient sleep | Associated with hormonal and semen quality changes |
Source: Clinical andrology literature review; British Columbia Medical Journal, 2022.
Beyond the population-level trends and environmental exposures, clinicians treating individual patients for fertility concerns consistently point to a well-established set of modifiable lifestyle factors. Obesity ranks among the most consistently cited, since excess body fat alters the hormonal balance between testosterone and estrogen and is independently linked to reduced semen quality across numerous studies. Tobacco use, heavy alcohol consumption, psychological stress, and insufficient sleep round out the list of factors most frequently flagged in clinical guidance for men being evaluated for fertility concerns, each with documented, if individually modest, associations with reduced sperm count or motility.
Heat exposure deserves particular mention because it’s one of the more counterintuitive and easily modified factors: the testes function optimally a few degrees below core body temperature, which is part of why they’re located outside the body, and prolonged exposure to added heat, whether from hot tubs, saunas, tight-fitting underwear, or even a laptop resting directly on the lap for extended periods, has been shown in clinical research to temporarily reduce sperm production. Unlike some of the more debated environmental and generational trends discussed elsewhere in this report, these lifestyle factors represent the areas where individual men and their doctors have the clearest, most actionable levers to pull, which is why fertility specialists typically address them first in any clinical evaluation before moving toward more invasive diagnostic or treatment steps.
IVF and Assisted Reproduction for Male Factor Statistics in the US 2026
Male Factor Infertility and Assisted Reproduction, US
IVF cycles causally linked to male infertility ~1 in 3 cycles
IVF cycles specifically due to prior vasectomy 7%
ART cycles used after failed vasectomy reversal 2.4%
Total IVF babies born in the US, 2022 91,771
| ART / IVF Metric | Figure |
|---|---|
| IVF cycles where male infertility is a contributing cause | About 1 in 3 cycles |
| IVF cycles specifically attributed to a prior vasectomy | 7% |
| ART cycles used following a failed vasectomy reversal | 2.4% |
| Total babies born via IVF in the US, 2022 | 91,771 |
| IVF cycles performed in the US, 2022 | 389,993 |
Source: UNSW fertility research compilation, 2022; US infertility statistics, CDC-derived, 2025.
Male factor infertility is now a routine, well-integrated part of the assisted reproduction landscape rather than an edge case. Roughly one in three IVF cycles performed involve male infertility as a contributing cause, and specific subcategories are well documented: 7% of cycles trace back to a prior vasectomy, while 2.4% of cycles occur after a vasectomy reversal has failed to restore natural fertility. Techniques like intracytoplasmic sperm injection (ICSI), where a single sperm is injected directly into an egg, have become a standard tool specifically for treating severe male factor cases, allowing pregnancies to occur even when natural fertilization would be highly unlikely due to low sperm count or poor motility. Readers wanting the fuller national picture on how these treatments fit into overall American fertility patterns can find comprehensive figures in the Infertility Statistics in the U.S report.
The scale of assisted reproduction in the US overall gives useful context for how significant a role male factor treatment now plays. American clinics performed 389,993 IVF cycles in 2022, resulting in 91,771 babies born that year, a figure that has grown steadily year over year. Because male factor infertility contributes to such a large share of those cycles, improvements in andrology lab techniques, including sperm freezing, sperm retrieval surgery for men with azoospermia, and increasingly precise sperm selection methods for ICSI, have become just as central to overall US fertility treatment outcomes as the better-known advances in egg retrieval and embryo transfer on the female side of reproductive medicine.
Sperm Banking and Fertility Preservation Statistics in the US 2026
| Sperm Banking Metric | Data |
|---|---|
| Standard cryopreservation storage temperature | -196°C in liquid nitrogen |
| Documented sperm quality degradation over long-term storage | None demonstrated in clinical research |
| Recommended abstinence period before sample collection | 2 to 5 days |
| Outcome equivalence, at-home vs. clinic-collected samples | Equivalent when protocol followed correctly |
| A common clinical population for banking | Men undergoing treatment for testicular cancer |
Source: Andrology and cryopreservation clinical literature, 2024-2026.
Sperm cryopreservation works on the same basic principle as egg freezing on the female side: cells are frozen at ultra-low temperatures, typically -196°C in liquid nitrogen, where biological activity essentially stops, preserving them for future use in treatments like IUI or IVF. A notable finding from recent clinical research is that, when performed correctly, sperm cryopreservation shows no significant degradation in viability or fertilization potential even over extended storage periods, meaning samples banked years or even decades earlier can still support successful conception. This durability is part of why sperm banking has become a standard offering for men undergoing treatments, such as chemotherapy for testicular cancer, that carry a known risk of impairing future fertility, giving them a fertility preservation option before treatment begins.
For men considering banking outside of a medical necessity, at-home collection kits have been shown to produce results equivalent to clinic collection, provided the recommended 2 to 5 day abstinence window beforehand is followed and the sample is shipped within the required timeframe, lowering a practical barrier that once required an in-person clinic visit. It’s worth noting that a single semen analysis is a snapshot rather than a definitive verdict on fertility, since sperm count and quality vary meaningfully between samples depending on recent illness, stress levels, and the exact abstinence period observed, which is why clinicians typically recommend a follow-up analysis before drawing firm conclusions from any one result. For readers interested in how the female equivalent of fertility preservation has evolved, including cost, success rates by age, and insurance coverage, the Egg Freezing Statistics in US report covers that landscape in detail.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
